Literature DB >> 11208593

Multiple aspects of mineralocorticoid selectivity.

N Farman1, M E Rafestin-Oblin.   

Abstract

Aldosterone regulates renal sodium reabsorption through binding to the mineralocorticoid receptor (MR). Because the glucocorticoid receptor (GR) is expressed together with the MR in aldosterone target cells, glucocorticoid hormones bound to GR may also intervene to modulate physiological functions in these cells. In addition, each steroid can bind both receptors, and the MR has equal affinity for aldosterone and glucocorticoid hormones. Several cellular and molecular mechanisms intervene to allow specific aldosterone regulatory effects, despite the large prevalence of glucocorticoid hormones in the plasma. They include the local metabolism of the glucocorticoid hormones into inactive derivatives by the enzyme 11beta-hydroxysteroid dehydrogenase; the intrinsic properties of the MR that discriminate between ligands through differential contacts; the possibility of forming homo- or heterodimers between MR and GR, leading to differential transactivation properties; and the interactions of MR and GR with other regulatory transcription factors. The relative contribution of each of these successive mechanisms may vary among aldosterone target cells (epithelial vs. nonepithelial) and according to the hormonal context. All these phenomena allow fine tuning of cellular functions depending on the degree of cooperation between corticosteroid hormones and other factors (hormonal or tissue specific). Such interactions may be altered in pathophysiological situations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11208593     DOI: 10.1152/ajprenal.2001.280.2.F181

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  47 in total

Review 1.  ENaCs and ASICs as therapeutic targets.

Authors:  Yawar J Qadri; Arun K Rooj; Catherine M Fuller
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

2.  Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia.

Authors:  Yannis Sainte Marie; Antoine Toulon; Ralf Paus; Eve Maubec; Aicha Cherfa; Maggy Grossin; Vincent Descamps; Maud Clemessy; Jean-Marie Gasc; Michel Peuchmaur; Adam Glick; Nicolette Farman; Frederic Jaisser
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

3.  Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.

Authors:  Eve Maubec; Cédric Laouénan; Lydia Deschamps; Van Tuan Nguyen; Isabelle Scheer-Senyarich; Anne-Catherine Wackenheim-Jacobs; Maud Steff; Stéphanie Duhamel; Sarah Tubiana; Nesrine Brahimi; Stéphanie Leclerc-Mercier; Béatrice Crickx; Claudine Perret; Selim Aractingi; Brigitte Escoubet; Xavier Duval; Philippe Arnaud; Frederic Jaisser; France Mentré; Nicolette Farman
Journal:  J Invest Dermatol       Date:  2015-02-10       Impact factor: 8.551

Review 4.  Glucocorticoid receptor signaling in health and disease.

Authors:  Mahita Kadmiel; John A Cidlowski
Journal:  Trends Pharmacol Sci       Date:  2013-08-14       Impact factor: 14.819

Review 5.  Collecting duct intercalated cell function and regulation.

Authors:  Ankita Roy; Mohammad M Al-bataineh; Núria M Pastor-Soler
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-28       Impact factor: 8.237

6.  Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heart.

Authors:  Celine Latouche; Yannis Sainte-Marie; Marja Steenman; Paulo Castro Chaves; Aniko Naray-Fejes-Toth; Geza Fejes-Toth; Nicolette Farman; Frederic Jaisser
Journal:  Endocrinology       Date:  2010-06-30       Impact factor: 4.736

Review 7.  The emerging role of aldosterone/mineralocorticoid receptors in the pathogenesis of erectile dysfunction.

Authors:  Fei Wu; Yun Lin; Qingyong Liu
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

8.  Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy.

Authors:  Francesco Pichi; Paola Carrai; Antonio Ciardella; Francine Behar-Cohen; Paolo Nucci
Journal:  Int Ophthalmol       Date:  2016-10-18       Impact factor: 2.031

9.  Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal muscle.

Authors:  Jessica A Chadwick; J Spencer Hauck; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Jill A Rafael-Fortney
Journal:  Physiol Genomics       Date:  2017-04-21       Impact factor: 3.107

10.  Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure.

Authors:  D du Cheyron; A Lesage; C Daubin; M Ramakers; P Charbonneau
Journal:  Intensive Care Med       Date:  2003-08-28       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.